Search

685 Result(s)
Sort by

Pioneering Pan-KRAS Research

Pioneering Pan-KRAS Research

Boehringer Ingelheim scientists are directly targeting KRAS, blocking feedback and ultimately getting ahead of resistance by investigating pan-KRAS approaches.
Spotlight on GPP

Spotlight on GPP

Emmanuelle Clerisme-Beaty, Head of Clinical Development and Medical Affairs, Dermatology, answers some frequently asked questions about GPP.
Circular economy

Circular economy

Boehringer Ingelheim strives to use resources for as long as possible, process them for reuse or recycle them.
Be green Japan

Be green Japan

Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply.
Our Partners_ViraTherapeutics

Our Partners_ViraTherapeutics

Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Obesity osteoarthritis in pets a blind spot

Obesity osteoarthritis in pets a blind spot

Same as with humans, body weight is just one indicator among many when it comes to a pet’s health status. However, there are some diseases associated with it. Learn more here.
Protein Degraders in Cancer

Protein Degraders in Cancer

Boehringer Ingelheim scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach
Stargardt Disease

Stargardt Disease

Stargardt Disease is a hereditary condition causing and progressive vision loss, typically during childhood or adolescence.
Understanding heart failure

Understanding heart failure

Heart failure is a complicated clinical condition which affects more than 60 million people worldwide. Find out more about the condition here.
COVID-19 Ivermectin Animal Health Not for Human Use

COVID-19 Ivermectin Animal Health Not for Human Use

Boehringer Ingelheim manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
SIRPα Cancer Immunology Research

SIRPα Cancer Immunology Research

Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
World milk day healthy cows

World milk day healthy cows

World Milk Day on June 1 serves to remind us of the importance of milk as global food, and to celebrate the dairy sector.
New approaches in the battle against heartworm disease

New approaches in the battle against heartworm disease

Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. We explore the potential for novel treatments and vaccines based on new knowledge and technology.
FuturePack

FuturePack

Boehringer Ingelheim has built a new special machine that enables efficient and sustainable packaging of small batches.
Complications of Diabetic Retinopathy

Complications of Diabetic Retinopathy

Both Diabetic Macular Edema and Ischemia are maculopathies, they specifically affect the macula, responsible for high visual acuity.